articleTop 10% cited
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
AIDS · 2002 · Vol. 16(7) · pp. 1031–1038
Neil French✉(Liverpool School of Tropical Medicine)Katherine J. GrayChristine WateraJessica NakiyingiEric LugadaMichael Moore(Liverpool School of Tropical Medicine)David G. Lalloo(Liverpool School of Tropical Medicine)James WhitworthCharles F. Gilks(Liverpool School of Tropical Medicine)
Abstract
Cryptococcal infection is an important contributor to mortality and suffering in HIV-infected Ugandans. Improvements in access to effective therapy of established disease are necessary. In addition, prevention strategies, in particular chemoprophylaxis, should be evaluated while awaiting the outcome of initiatives to make antiretroviral therapy more widely available.
Fungal Infections and StudiesAntifungal resistance and susceptibilityPneumocystis jirovecii pneumonia detection and treatmentMedicineCohortCryptococcosisMortality rateCryptococcal meningitisCryptococcus neoformansChemoprophylaxisDiseasePediatricsAIDS-Related Opportunistic Infections
MeSH terms
AdolescentAdultAntigens, FungalCryptococcosisCryptococcus neoformansDouble-Blind MethodFemaleHumansMaleMiddle AgedUgandaCohort StudiesSurvival AnalysisRandomized Controlled Trials as TopicSeroepidemiologic Studies
Funding
- Medical Research Council
Citations
423
FWCI
6.34
field-weighted impact
References
28
Percentile
97%
vs. same field & year
Citations per year
Cited by
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases · 2010 · 2,634 citations
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
AIDS · 2009 · 2,039 citations
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
The Lancet Infectious Diseases · 2017 · 1,926 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.